HOSA 2024 SET 1

5.0(1)
studied byStudied by 8 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/150

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

151 Terms

1
New cards

FDA (food and drug administration)

-approve new drugs to be sold in the US -process New Drug Applications (NDA) -regulate package inserts -regulate drug advertising -issue recalls -federal agency

2
New cards

DEA (Drug Enforcement Agency)

-federal agency -enforce the CSA ( controlled substances act) -track controlled substances manufactured and sold -investigates all violations involving controlled substances -set the DEA Sch. Definitions -issue DEA numbers

3
New cards

BOP (Board of Pharmacy) (each state)

-regulate licensing of pharmacists -regulate licensing of pharmacy technicians -set state laws/ requirements -outline the operating guidelines in the pharmacy -investigate violations of the operating guidelines -determine state regulated controlled substances -state agency

4
New cards

Joint Commission on Accreditation of Healthcare Organizations

-watches over healthcare organizations -third party auditors/ regulators for insurance providers

5
New cards

DEA Schedule I

-no accepted medical use -extremely high potential for abuse -high potential for psychological and physical dependency -ex. weed

6
New cards

DEA Schedule II

-does have medical use -high potential for abuse -relative potential for psychological and physical dependency -ex. oxycodone

7
New cards

DEA Schedule III

-does have medical use -moderate abuse potential exits -ex. vicodin and tylenol w/ codeine

8
New cards

DEA Schedule IV

-abuse potential exists -ex. ambien

9
New cards

DEA Schedule V

-lowest abuse potential -ex. cough medicine w/ codeine or anti-diarrheas

10
New cards

DEA Form 222

-must be used whenever Sch I or II drugs are bought

11
New cards

DEA number verification

-add the 1st

12
New cards

sig

-tells pharm techs how to dispense it -also printed on the prescription it is dispensed in but translated into regular words for the patient

13
New cards

Expiration dates: DEA Sch II

no expiration

14
New cards

Expiration dates: DEA Sch III thru V

6 months

15
New cards

Expiration dates: Legend Drugs

12 months

16
New cards

Refills: DEA Schedule II

no refills allowed

17
New cards

Refills: DEA Schedule III thru V

-up to 5

18
New cards

Refills: Legend Drugs

up to 12 months worth

19
New cards

DEA Controlled Drug Prescriptions must contain at least:

-date of prescription issue -patient's name and address -practitioner's name

20
New cards

Schedule II drug prescription:

-must be manually signed by the practitioner. no exceptions -may not be faxed or called in

21
New cards

FDA Recall Class I

would be used in a case where there is a probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

22
New cards

FDA Recall Class II

would be used in a case where use of a violative product may cause temporary health problems and the probability of serious adverse health consequence is remote

23
New cards

FDA Recall Class III

may be used in a situation in which use of a violative product is not likely to cause adverse health consequence

24
New cards

FDA Market Withdrawal

appropriate when a product has a minor violation that would be not subject to FDA legal action. the manufacture must remove the product from distribution markets or correct the violation. "a product removed from the market due to tampering

25
New cards

FDA Medical Device Safety Alert

used only for medical apparatus equipment. this is when a medical device may present an unreasonable risk of substantial harm. in some cases

26
New cards

NDA Process: Initial Development: Pre Clinical

pre-clinical (animal) testing

27
New cards

NDA Process: Initial Development: Investigational New Drug Review (IND)

-review of pre-clinical trial results -determination of safety to use on humans -authorization to ship across state lines

28
New cards

NDA Process: New Drug Clinical Trials: Phase I

-involves 25-100 volunteers -safety tolerated dosage determined -identification of major side effects -emphasis on safety and maximum tolerated dosages

29
New cards

NDA Process: New Drug Clinical Trials: Phase II

-involves 100-300 volunteers -emphasis on the drug effect against what it's designed to treat -effets compared with similar patients receiving different treatments

30
New cards

NDA Process: New Drug Clinical Trials: Phase III

-involves 300-3000 volunteers -emphasis on the drugs overall effect -effects compared with patients taking placebos -study of different population and different dosages -testing the drug in combination with other drugs -final phase before presenting to FDA for approval

31
New cards

NDA Process: New Drug Post Approval Trials: Phase IV

-ongoing/post approval trials -health-care professionals to report any adverse findings -lasts eternally

32
New cards

NDA Process Time

-can usually take 12-15 years -patent only last 20 years from the time the application for patent was filled

33
New cards

Federal Food and Drug Act of 1906

-known as the Pure Food and Drug Act -provided authority for federal inspection of meat products and prohibited the sale of adulterated foods -required that "secret elixirs" containing ingredients like: cocaine

34
New cards

Narcotic Tax Act of 1914

-known as the Harrison Narcotic Act -provided authority for the IRS to collect taxes on Opiates thru tax stamps -required that any entity which produced

35
New cards

Federal Food

Drug and Cosmetic Act of 1938

36
New cards

The Durham-Humphrey Amendment of 1951

-created a distinction between "OTC" and "Legend Drugs" -required legend drugs to carry the statement: "Caution: Federal law prohibits dispensing without a prescription." -emphasis on this act was to insure safety through qualified medical supervision

37
New cards

The Kefauver-Harris Amendment of 1962

-known as the "Drug Efficacy Amendment" -required drug manufacturers to provide proof of the effectiveness and safety of their drugs before approval -required drug advertising to be more closely regulated and disclose accurate information about side effects

38
New cards

The Bureau of Narcotics and Dangerous Drugs (BNDD)

-predecessor agency of the DEA -BNDD merged into the DEA in 1973

39
New cards

Drug Abuse Prevention/ Control Act of 1970

-known as the CSA -completely replaced the Harrison Act -required the use of DEA numbers -required comprehensive record keeping and transaction tracking -enforced the DEA under the US Dept of Justice

40
New cards

Poison Prevention Packaging Act of 1970

-also known as the PPPA -designed to reduce the risk of children ingesting dangerous substances -required locking caps on most prescription

41
New cards

Combat Methamphetamine Epidemic Act (2005)

-enacted to regulate the OTC sales of pseudoephedrine -identity and address of each purchaser to be kept for two years -daily sales of regulated products not exceed 3.6 grams -30 day purchase limit not to exceed 9 grams -30 day purchase via mail order not to exceed 7.5 grams

42
New cards

National Drug Code (NDC)

-used to identify legend drugs -part of the drug listing act of 1972

43
New cards

NDC: ####-xxxx-xx

-identifies the drug's manufacturer -number is unique to the maker or re-packager of the product

44
New cards

NDC: xxxx-####-xx

-identifies the product -number unique to the formulation and strength of the product

45
New cards

NDC: xxxx-xxxx-##

-identifies the packaging -unique to the size and quantity of the product

46
New cards

q

every

47
New cards

qH

every hours

48
New cards

qAM

every morning

49
New cards

qPM

every evening

50
New cards

qHS

every bedtime

51
New cards

qD

every day

52
New cards

qOD

every other day

53
New cards

qWK

every week

54
New cards

qMO

every month

55
New cards

q__*

every __ hours

56
New cards

q__H

every __ hours

57
New cards

BID

twice a day

58
New cards

TID

three a day

59
New cards

QID

four a day

60
New cards

X__D

times __ days

61
New cards

TDS

3 times a day

62
New cards

C

with

63
New cards

AC

before a meal

64
New cards

PC

after a meal

65
New cards

HS

at bedtime

66
New cards

PRN

as needed

67
New cards

UD

as directed

68
New cards

AA

of each

69
New cards

QS

quantity sufficient

70
New cards

GTT

drop

71
New cards

OD

right eye

72
New cards

OS

left eye

73
New cards

OU

both eyes

74
New cards

AD

right ear

75
New cards

AS

left ear

76
New cards

AU

both ears

77
New cards

PO

by mouth/oral

78
New cards

SL

sub-lingual

79
New cards

NG

naso gastic

80
New cards

BUCCAL

cheek/gum

81
New cards

PR

rectally

82
New cards

PV

vaginally

83
New cards

SUPP

suppositiory

84
New cards

TAB

tablet

85
New cards

CAP

capsule

86
New cards

IM

intramuscular

87
New cards

SQ

sub-cutaneous

88
New cards

IV

intravenous

89
New cards

IC

intra cardiac

90
New cards

INJ

injection

91
New cards

STAT

immediately

92
New cards

Dosage Form: Enteral Medication

-given orally and pass through the GI tract to be absorbed into the bloodstream and metabolized by the liver -includes oral

93
New cards

Dosage Form: Parenteral medication

-injected or placed into the body tissues and do not pass through the liver before entering the bloodstream -can include injections

94
New cards

Dosage From: Injectable Drugs

-usually in the form of solution or powders -mixed with a sterile diluent to render an injectable solution

95
New cards

Topical

-applied to the skin surface or a mucous membrane

96
New cards

Tablets

-to form a tablet

97
New cards

Capsules

-to form a capsule

98
New cards

Caplet

-an oval shaped tablet

99
New cards

Oral Suspension

-drug is mixed with

100
New cards

Syrups

-contain a high concentration of sucrose or sugar to sweeten